# Penn Biobank Return of Research Results Program

> **NCT04242667** · NA · COMPLETED · sponsor: **Abramson Cancer Center at Penn Medicine** · enrollment: 260 (actual)

## Conditions studied

- Cancer
- Cardiovascular Diseases
- Hereditary Cancer
- Hereditary Cardiac Amyloidosis

## Interventions

- **BEHAVIORAL:** e-Health (web-based) disclosure portal
- **BEHAVIORAL:** Provider mediated disclosure

## Key facts

- **NCT ID:** NCT04242667
- **Lead sponsor:** Abramson Cancer Center at Penn Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-01
- **Primary completion:** 2023-04-11
- **Final completion:** 2023-08-01
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2024-07-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04242667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04242667, "Penn Biobank Return of Research Results Program". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04242667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*